Annexin A7 (ANXA7), originally named synexin, was the first annexin to be discovered four decades ago15 and has since been associated with tumor progression and reduced overall survival in cancers including hepatocellular carcinoma and breast cancer16,17. Here, ANXA7 is linked to hepatocellular carcinoma.